Experimental 1070nm Intranasal Stimulation

Intranasal Near-Infrared Light Therapy

Developed by the Quietmind Foundation, this intranasal photobiomodulation (iPBM) device delivers a continuous 80mW of 1070nm infrared light to the nasal cavity.¹ This device is being studied as part of a case series investigation to evaluate how it might support the immune response to COVID-19 and mitigate long-COVID symptoms, such as brain fog.

The intranasal iPBM device can be used in conjunction with the Neuromatrix 1070, a programmable, four-quadrant photobiomodulation system, to deliver near-infrared stimulation safely and reliably.